How to Improve Pancreatic Cancer Life Expectancy

How to Improve Pancreatic Cancer Life Expectancy

Pancreatic cancer is a disease that primarily affects the pancreas. The pancreas is mostly located in the interior parts below the abdomen and the stomach. The pancreas is essential because it releases enzymes to catalyze the digestion process, and also helps maintain blood sugar levels stable.

Sadly, pancreatic cancer is rarely detected, and an effective treatment can be difficult to find. The symptoms of pancreatic cancer are usually felt at the peak of the disease—which gives the patient very little time to find a treatment.

The life expectancy of individuals who are diagnosed with pancreatic cancer is usually about five to eight months. Albeit pancreatic cancer life expectancy is very low, it is still possible to prolong the life expectancy of pancreatic cancer. The following information below shows a detailed guide on how to increase pancreatic cancer life expectancy, and how to treat pancreatic cancer symptoms.

Read more at Suite101: How to Improve Pancreatic Cancer Life Expectancy http://cancer.suite101.com/article.cfm/how-to-improve-pancreatic-cancer-life-expectancy#ixzz0n2bUupVV

Ulcerative colitis in men linked to increased risk for pancreatic cancer | HemOncToday

Ulcerative colitis in men linked to increased risk for pancreatic cancer | HemOncToday

Patients with inflammatory bowel disease had six times the risk for developing pancreatic neoplasia, and men with ulcerative colitis had five times the risk for developing pancreatic neoplasia in a prospective study of more than 2,800 patients.

Because there is a known association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis and cholangiocarcinoma within the bile ducts, as well as between primary sclerosing cholangitis and pancreatic cancer, researchers suspected that patients with IBD would be at greater risk for the development of pancreatic cancer.

To test their supposition, researchers prospectively examined 2,877 adults with IBD who were treated in the University of Utah Health System from January 1996 to December 2006. The IBD cohort was then matched to the Utah Cancer Registry and the Utah Population Database to determine the number of patients diagnosed with IBD and pancreatic cancer.